Metastatic (stage 4) bladder cancer

طلب موعد

Survival rates

The outlook for people diagnosed with metastatic bladder cancer is improving. When the cancer spreads, it's not likely to be cured. But new treatments are helping people with this diagnosis live longer.

People diagnosed with cancer often want to know the survival rates. Some people find these numbers helpful because they offer a general sense of what to expect and help put the diagnosis in perspective. Others don't find the survival rates helpful. The statistics may feel confusing, discouraging or overwhelming.

Survival statistics can provide general information about the seriousness of the situation, but they can't predict what will happen in any one person. These statistics include thousands of people with the same cancer, including people of different ages, with different health conditions and with different treatment histories.

Keep in mind that your healthcare team uses much more detailed information when talking with you about your individual prognosis and treatment options.

Survival statistics

The U.S. National Cancer Institute (NCI) tracks cancer survival rates in the United States. According to the NCI, the five-year relative survival rate for metastatic bladder cancer is about 10%.

Survival rates take time to collect. People included in the most recent statistics may not have had access to the latest treatments, including new immunotherapy medicines and antibody-drug conjugates.

These survival statistics only include people who had metastatic cancer when first diagnosed with bladder cancer. This isn't common. Most people with metastatic cancer were treated for bladder cancer in the past.

What affects your outlook

The outlook, also called prognosis, describes how likely it is that a cancer can be treated successfully or cured. Healthcare professionals estimate prognosis using information about the cancer and your overall health. To better understand your personal outlook, talk with your healthcare team. Your team can explain the factors that affect your situation.

Things that can affect the outlook for metastatic bladder cancer include:

  • Where the cancer spreads. Bladder cancer that spreads to the lymph nodes has a better outlook than cancer that spreads to the bones or the organs.
  • Your overall health. Being in generally good health may help you cope better with bladder cancer treatments.
طلب تحديد موعد
Stagesالأطباء والأقسام
11/09/2026
  1. DeVita VT Jr, et al., eds. Cancer of the bladder, ureter and renal pelvis. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. ProQuest Ebook Central. Wolters Kluwer; 2023. Accessed Aug. 28, 2026.
  2. Dmochowski RR, et al., eds. Management of muscle-invasive and metastatic bladder cancer. In: Campbell-Walsh-Wein Urology. 13th ed. Elsevier; 2026. https://www.clinicalkey.com. Accessed Aug. 28, 2026.
  3. American College of Surgeons. Urinary bladder. In: AJCC Cancer Staging System. American College of Surgeons; 2026. https://online.statref.com. Accessed Aug. 28, 2026.
  4. Bladder cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1417. Accessed Aug. 28, 2026.
  5. Bellmunt J, et al. Treatment of metastatic urothelial carcinoma of the bladder and urinary tract. https://www.uptodate.com/contents/search. Accessed Aug. 28, 2026.
  6. Lotan Y, et al. Clinical presentation, diagnosis and staging of bladder cancer. https://www.uptodate.com/contents/search. Accessed Aug. 28, 2026.
  7. Foote RL, et al., eds. Bladder cancer. In: Gunderson & Tepper's Clinical Radiation Oncology. 6th ed. Elsevier; 2026. https://www.clinicalkey.com. Accessed Aug. 28, 2026.
  8. Bladder cancer symptoms. National Cancer Institute. https://www.cancer.gov/types/bladder/symptoms. Accessed Aug. 28, 2026.
  9. Bladder cancer diagnosis. National Cancer Institute. https://www.cancer.gov/types/bladder/diagnosis. Accessed Sept. 1, 2026.
  10. PET/CT. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/pet. Accessed Sept. 1, 2026.
  11. Abidoye O, et al. Lines of therapy for locally advanced/metastatic urothelial carcinoma: The new paradigm. JCO Oncology Practice. 2025; doi:10.1200/OP-24-00758.
  12. Liu MA, et al. Management of oligometastatic and locally recurrent urothelial carcinoma. Current Oncology Reports. 2024; doi:10.1007/s11912-024-01523-8.
  13. Palliative care. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1454. Accessed Sept. 1, 2026.
  14. Cancer stat facts: Bladder cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/urinb.html. Accessed Aug. 28, 2026.
  15. Survival rates for bladder cancer. American Cancer Society. https://www.cancer.org/cancer/types/bladder-cancer/detection-diagnosis-staging/survival-rates.html. Accessed Sept. 1, 2026.
  16. Gallicchio L, et al. Estimation of the number of individuals living with metastatic cancer in the United States. Journal of the National Cancer Institute. 2022; doi:10.1093/jnci/djac158.

Metastatic (stage 4) bladder cancer